Nursing Central is the award-winning, complete mobile solution for nurses and students. Look up information on diseases, tests, and procedures; then consult the database with 5,000+ drugs or refer to 65,000+ dictionary terms. Explore these free sample topics:
-- The first section of this topic is shown below --
To evaluate the effectiveness of EPO administration as a treatment for anemia, especially related to chemotherapy and kidney disease.
There are no food, fluid, activity, or medication restrictions unless by medical direction.
Method: Immunochemiluminometric assay.
|Age||Conventional and SI Units||Conventional and SI Units|
|0–3 yr||1.7–17.9 milli-international units/mL||2.1–15.9 milli-international units/mL|
|4–6 yr||3.5–21.9 milli-international units/mL||2.9–8.5 milli-international units/mL|
|7–9 yr||1.1–13.5 milli-international units/mL||2.1–8.2 milli-international units/mL|
|10–12 yr||1.1–14.1 milli-international units/mL||1.1–9.1 milli-international units/mL|
|13–15 yr||2.2–14.4 milli-international units/mL||3.8–20.5 milli-international units/mL|
|16–18 yr||1.5–15.2 milli-international units/mL||2.1–14.2 milli-international units/mL|
|Adult||4.2–27.8 milli-international units/mL||4.2–27.8 milli-international units/mL|
|Based on normal hemoglobin and hematocrit. Values may be decreased in older adults due to the effects of medications and the presence of multiple chronic or acute diseases with or without muted symptoms.|
Critical Findings and Potential Interventions